Soumitro Pal Selected Research

Soumitro Pal Research Topics

Disease

26	Neoplasms (Cancer) 12/2023 - 06/2003
21	Kidney Neoplasms (Kidney Cancer) 12/2023 - 02/2004
4	Renal Cell Carcinoma (Grawitz Tumor) 12/2023 - 01/2017
3	Neoplasm Metastasis (Metastasis) 11/2017 - 11/2010
2	Carcinogenesis 01/2021 - 12/2008
2	Carcinoma (Carcinomatosis) 07/2008 - 06/2003
2	Breast Neoplasms (Breast Cancer) 10/2006 - 06/2003
1	Infections 01/2019
1	Tuberous Sclerosis (Bourneville's Disease) 01/2015
1	Atherosclerosis 06/2004
1	Pancreatic Neoplasms (Pancreatic Cancer) 02/2004
1	Hypoxia (Hypoxemia) 02/2004
1	Adenocarcinoma 02/2004
1	Male Breast Neoplasms (Male Breast Cancer) 06/2003

Drug/Important Bio-Agent (IBA)

9	Calcineurin InhibitorsIBA 01/2017 - 07/2008
8	Proteins (Proteins, Gene)FDA Link 07/2020 - 06/2003
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2013 - 02/2004
7	Heme Oxygenase-1IBA 12/2023 - 11/2010
6	honokiolIBA 12/2023 - 09/2013
6	Chemokine ReceptorsIBA 07/2020 - 10/2006
6	Immunosuppressive Agents (Immunosuppressants)IBA 07/2020 - 07/2008
6	Sirolimus (Rapamycin)FDA Link 07/2020 - 08/2010
5	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2023 - 03/2015
4	LigandsIBA 01/2022 - 06/2004
4	EnzymesIBA 01/2017 - 09/2011
3	AntioxidantsIBA 12/2023 - 01/2019
3	ChemokinesIBA 02/2014 - 10/2006
3	CytokinesIBA 09/2013 - 08/2010
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 09/2013 - 07/2008
3	Small Interfering RNA (siRNA)IBA 11/2010 - 10/2006
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2017
2	Nuclear Proteins (Protein, Nuclear)IBA 07/2020 - 02/2014
2	Sorafenib (BAY 43-9006)FDA Link 01/2019 - 09/2012
2	Annexin A5IBA 09/2011 - 11/2010
2	Messenger RNA (mRNA)IBA 11/2010 - 07/2008
2	CXCR3 ReceptorsIBA 12/2008 - 10/2006
1	ranatachykinin CIBA 12/2023
1	Transcription Factors (Transcription Factor)IBA 12/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2023
1	cabozantinibIBA 12/2023
1	Tryptophan (L-Tryptophan)FDA Link 01/2021
1	Arginine (L-Arginine)FDA Link 01/2021
1	Glutamine (L-Glutamine)FDA Link 01/2021
1	B7-H1 AntigenIBA 11/2017
1	Neutralizing AntibodiesIBA 03/2015
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 03/2015
1	chelerythrineIBA 01/2015
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2015
1	trans-sodium crocetinate (crocetin)IBA 01/2015
1	Cytostatic AgentsIBA 01/2015
1	p38 Mitogen-Activated Protein KinasesIBA 02/2014
1	TOR Serine-Threonine KinasesIBA 01/2011
1	Mechanistic Target of Rapamycin Complex 2IBA 12/2008
1	Chemokine CXCL10IBA 10/2006
1	protein kinase C zetaIBA 02/2004
1	Insulin ReceptorIBA 02/2004
1	Somatomedin Receptors (Somatomedin Receptor)IBA 02/2004
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2004
1	AntigensIBA 06/2003
1	Glycoproteins (Glycoprotein)IBA 06/2003
1	Complex MixturesIBA 06/2003
1	tumor-associated antigen 72IBA 06/2003
1	DEAE-CelluloseIBA 06/2003
1	AntibodiesIBA 06/2003

Therapy/Procedure

6	Therapeutics 12/2023 - 08/2010
5	Organ Transplantation 01/2022 - 07/2008
5	Transplantation 01/2022 - 07/2008
3	Kidney Transplantation 01/2022 - 08/2012